Oxford scientists develop Ebola vaccine for Bundibugyo strain, trials approved
Oxford scientists created a vaccine against the Bundibugyo Ebola strain in eight weeks. UK regulators approved first human trials, and volunteers are needed.
The Full Story
A plain summary built from the channels that reported this story.
Scientists at the University of Oxford have developed a vaccine against the Bundibugyo strain of Ebola, the strain responsible for the ongoing outbreak in the Democratic Republic of Congo. The vaccine was created in just eight weeks using the same technology that produced the Oxford-AstraZeneca Covid vaccine. UK regulators have approved the first human trials, and the Oxford Vaccine Group is recruiting 50 healthy volunteers aged 18 to 55 to test the vaccine for safety and immune response.
The first volunteer, Ed Hunt, received the vaccine in Oxford, becoming the first person in the world to be immunised against this strain. The trial will primarily monitor safety, but scientists will also check whether the vaccine prompts a strong immune response, which would suggest it can protect against Ebola. Volunteers may experience a sore arm or a fever for 24 hours, and researchers will watch for rare risks such as blood clots, similar to those seen with the Oxford-AstraZeneca Covid vaccine, which was given to hundreds of millions of people safely.
The need for the vaccine is urgent. The outbreak in DR Congo has infected more than 2,500 people and caused over 1,000 deaths. The Bundibugyo species kills around one in three of those infected. There are three other vaccines against this strain in development globally, but the Oxford jab is the first to enter human trials. Trials in Africa are expected to follow soon after the Oxford study begins immunising volunteers in the coming weeks.
On screen
Stills are sampled automatically at 60-second intervals. Where shown, the still is the nearest available frame from the relevant broadcast segment and is included to show what was on screen during that part of the broadcast. A still may not correspond to the exact second of a quoted phrase.
Key Claims
Claims reported during this story's coverage, mapped by channel. Ordered by how many channels carried each claim.
| Claim | BBC One |
|---|---|
| Reported DR Congo Ebola outbreak figures: 2,000–2,500 cases and 700–1,000 deaths. | |
| The Bundibugyo strain of Ebola kills around one in three of those infected. | |
| The Ebola vaccine was developed in eight weeks. | |
| The first volunteer, Ed Hunt, received the Ebola vaccine in Oxford. | |
| The trial will monitor safety and immune response without exposing volunteers to Ebola. | |
| The vaccine uses the same technology as the Oxford-AstraZeneca Covid vaccine. | |
| UK regulators approved the first human trials of an Oxford Ebola vaccine targeting the Bundibugyo strain, with the Oxford Vaccine Group seeking 50 volunteers aged 18 to 55. |
Channel Perspectives
What each channel focused on, with key quotes.
This broadcast focused on the speed of vaccine development and the urgent need for volunteers, framing the story as a race against time. It provided detailed explanation of the technology and side effects, and included context of the DR Congo outbreak with case and death numbers.
- “They've been working flat out to create a vaccine against Ebola and have done it in just eight weeks.”
- “So we're using the the same vaccine technology that was used to make the Oxford AstraZeneca Covid vaccine”
- “The Oxford vaccine group wants to recruit 50 healthy volunteers aged 18 to 55 to test the vaccine for safety and immune response.”
This broadcast included the Ebola story as part of a wider news bulletin, also covering an arrest and England team training. The Ebola segment emphasised regulatory approval and the outbreak's toll, with slightly different phrasing on case numbers. It repeated the same key quotes about technology and volunteer recruitment.
- “Regulators have given approval for the first human trials of a pioneering Ebola vaccine in the UK”
- “So far nearly 2,000 people have been infected and about 700 have died.”
- “So we're using the the same vaccine technology that was used to make the Oxford-AstraZeneca Covid vaccine”
This broadcast provided an update that the first volunteer had been vaccinated, and included an interview with medical editor Fergus Walsh. It gave updated case numbers (over 2,500 cases and 1,000 deaths) and focused on the safety monitoring and immune response testing. The tone was more immediate, highlighting the milestone of the first jab.
- “Man in Oxford has become the first person in the world to be given a new vaccine against the Ebola strain”
- “Ed Hunt is one of 50 volunteers being recruited by the Oxford vaccine group”
- “current figures are more than two and a half thousand cases of Ebola in DR Congo and over a thousand deaths”
Broadcast Timeline
News broadcasts tracked for this story, in time order.